OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy
Annamaria Vezzani, Silvia Balosso, Teresa Ravizza
Nature Reviews Neurology (2019) Vol. 15, Iss. 8, pp. 459-472
Closed Access | Times Cited: 652

Showing 1-25 of 652 citing articles:

Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options
Wolfgang Löscher, Heidrun Potschka, Sanjay M. Sisodiya, et al.
Pharmacological Reviews (2020) Vol. 72, Iss. 3, pp. 606-638
Open Access | Times Cited: 601

Psychiatric face of COVID-19
Luca Steardo, Luca Steardo, Alexei Verkhratsky
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 212

30 years of second-generation antiseizure medications: impact and future perspectives
Emilio Perucca, Martin J. Brodie, Patrick Kwan, et al.
The Lancet Neurology (2020) Vol. 19, Iss. 6, pp. 544-556
Closed Access | Times Cited: 182

Inflammation and reactive oxygen species as disease modifiers in epilepsy
Gaetano Terrone, Silvia Balosso, Alberto Pauletti, et al.
Neuropharmacology (2019) Vol. 167, pp. 107742-107742
Closed Access | Times Cited: 165

Neuroinflammation — a common thread in neurological disorders
Nils Erik Gilhus, Günther Deuschl
Nature Reviews Neurology (2019) Vol. 15, Iss. 8, pp. 429-430
Closed Access | Times Cited: 160

Neuroinflammation and Proinflammatory Cytokines in Epileptogenesis
Alireza Soltani Khaboushan, Niloufar Yazdanpanah, Nima Rezaei
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1724-1743
Closed Access | Times Cited: 153

Dopamine, Immunity, and Disease
Breana Channer, Stephanie Matt, Emily Nickoloff-Bybel, et al.
Pharmacological Reviews (2022) Vol. 75, Iss. 1, pp. 62-158
Open Access | Times Cited: 146

Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier
Jia Li, Meng Zheng, Olga Shimoni, et al.
Advanced Science (2021) Vol. 8, Iss. 16
Open Access | Times Cited: 131

A long way to go: caspase inhibitors in clinical use
Shanel Dhani, Yun Zhao, Boris Zhivotovsky
Cell Death and Disease (2021) Vol. 12, Iss. 10
Open Access | Times Cited: 117

Seizures and Epilepsy After Stroke: Epidemiology, Biomarkers and Management
Marian Galovic, Carolina Ferreira‐Atuesta, Laura Abraira, et al.
Drugs & Aging (2021) Vol. 38, Iss. 4, pp. 285-299
Open Access | Times Cited: 116

Astrocytes in the initiation and progression of epilepsy
Annamaria Vezzani, Teresa Ravizza, Peter Bedner, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 12, pp. 707-722
Open Access | Times Cited: 102

Lipid-accumulated reactive astrocytes promote disease progression in epilepsy
Zhang‐Peng Chen, Suji Wang, Xiansen Zhao, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 4, pp. 542-554
Closed Access | Times Cited: 92

Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling
Pavanish Kumar, Amanda Jin Mei Lim, Sharifah Nur Hazirah, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 7, pp. 956-966
Open Access | Times Cited: 77

The Interconnected Mechanisms of Oxidative Stress and Neuroinflammation in Epilepsy
Anna L. M. Parsons, Eboni M. V. Bucknor, Enrico Castroflorio, et al.
Antioxidants (2022) Vol. 11, Iss. 1, pp. 157-157
Open Access | Times Cited: 69

Neuroinflammatory mediators in acquired epilepsy: an update
Yu Chen, Marwa M. Nagib, Nelufar Yasmen, et al.
Inflammation Research (2023) Vol. 72, Iss. 4, pp. 683-701
Open Access | Times Cited: 59

Cytokines inNew‐OnsetRefractory Status Epilepticus Predict Outcomes
Aurélie Hanin, Jorge Cespedes, Karim Dorgham, et al.
Annals of Neurology (2023) Vol. 94, Iss. 1, pp. 75-90
Open Access | Times Cited: 55

Neuroinflammation microenvironment sharpens seizure circuit
Benjamín Villasana‐Salazar, Annamaria Vezzani
Neurobiology of Disease (2023) Vol. 178, pp. 106027-106027
Open Access | Times Cited: 43

Chronic effects of inflammation on tauopathies
Connor Langworth-Green, Saisha Patel, Zane Jaunmuktane, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 5, pp. 430-442
Open Access | Times Cited: 43

mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment
Teresa Ravizza, Mirte Scheper, Rossella Di Sapia, et al.
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 5, pp. 334-350
Closed Access | Times Cited: 27

New epilepsy therapies in development
Pavel Klein, Rafal M. Kaminski, Matthias J. Koepp, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 9, pp. 682-708
Closed Access | Times Cited: 24

Pathophysiology to Risk Factor and Therapeutics to Treatment Strategies on Epilepsy
Ana Paula de Araújo Boleti, Pedro Henrique de Oliveira Cardoso, Breno Emanuel Farias Frihling, et al.
Brain Sciences (2024) Vol. 14, Iss. 1, pp. 71-71
Open Access | Times Cited: 16

The interplay between microbiota and brain-gut axis in epilepsy treatment
Hanxiao Zhu, Wei Wang, Yun Li
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 16

Reactive Glia Inflammatory Signaling Pathways and Epilepsy
Pascual Sanz, María Adelaida García-Gimeno
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4096-4096
Open Access | Times Cited: 133

Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics
Sudip Mukherjee, Vijay Sagar Madamsetty, Dwaipayan Bhattacharya, et al.
Advanced Functional Materials (2020) Vol. 30, Iss. 35
Closed Access | Times Cited: 117

Page 1 - Next Page

Scroll to top